66 related articles for article (PubMed ID: 29797935)
61. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
62. FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.
Song Y; Zhou X; Bai W; Ma X
Tumour Biol; 2015 Jun; 36(6):4197-202. PubMed ID: 25586348
[TBL] [Abstract][Full Text] [Related]
63. MicroRNA-132 sensitizes nasopharyngeal carcinoma cells to cisplatin through regulation of forkhead box A1 protein.
Li YL; Zhao YG; Chen B; Li XF
Pharmazie; 2016 Dec; 71(12):715-718. PubMed ID: 29442000
[TBL] [Abstract][Full Text] [Related]
64. microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.
Yuan TZ; Zhang HH; Lin XL; Yu JX; Yang QX; Liang Y; Deng J; Huang LJ; Zhang XP
Mol Med Rep; 2017 Apr; 15(4):2223-2228. PubMed ID: 28260044
[TBL] [Abstract][Full Text] [Related]
65. Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin.
Xie SM; Fang WY; Liu Z; Wang SX; Li X; Liu TF; Xie WB; Yao KT
J Transl Med; 2008 Oct; 6():55. PubMed ID: 18834541
[TBL] [Abstract][Full Text] [Related]
66. [Investigation of CXCR4 mediated chemoresistance in nasopharyngeal carcinoma cell line CNE2].
Song XY; Shang XL; Zhang YT; Lin YT; Xu GG; Xue G; Zhang QJ; Zou F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(11):887-891;896. PubMed ID: 29797935
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
